The authors declare which the research was executed within the absence of any business or money relationships that would be construed as a possible conflict of interest. Sifalimumab might suppress the abnormal immune action related to lupus by binding to many interferon-alpha subtypes found inside the serum of lupus people. https://eugeneo887coy0.blogdomago.com/profile